Intratumoral PD-1-directed IL-2 expression via oncolytic vaccinia virus elicits superior antitumor effects with enhanced safety. [PDF]
Chen L +9 more
europepmc +1 more source
Inhibitory Effect of Interleukin-24 on Programmed Death Ligand 1 Expression via a Eukaryotic Translation Initiation Factor 2 Alpha Kinase 2-Dependent Pathway in Human Triple-Negative Breast Cancer. [PDF]
Smith S +6 more
europepmc +1 more source
Ability of lactylation-related genes to stratify patients with ovarian cancer and predict immunotherapy response. [PDF]
Tang Z +7 more
europepmc +1 more source
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer. [PDF]
Ghiringhelli F +23 more
europepmc +1 more source
Efficacy of transarterial chemoembolization combined with PD-1 versus PD-L1 inhibitors in mass-forming intrahepatic cholangiocarcinoma: a multicenter retrospective study. [PDF]
Hu Y +7 more
europepmc +1 more source
Impact of proton pump inhibitor use on immune-related adverse events in patients with non-small cell lung cancer: a retrospective study. [PDF]
Miyamoto I +8 more
europepmc +1 more source
Elucidating shared genes and pathways in programmed cell death with necrotizing enterocolitis: insights into novel therapeutic targets and glutathione. [PDF]
Zou P +15 more
europepmc +1 more source
PD-1/PD-L1 blockade in HIV-associated advanced lung cancer: from mechanisms to clinical practice. [PDF]
Chen R, Ren S, Tang H, Wu Q.
europepmc +1 more source

